Please enable JavaScript in your browser. 
Skip to main content
Drug Information Portal National Library of Medicine
       Home    Substance
Drug Name: BR96-doxorubicin immunoconjugate
Description: A chimeric monoclonal antibody, BR96 & doxorubicin immunoconjugate developed for the treatment of tumors that express Lewis(y)-related antigens. 

Site Map, Contact Us, Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act
Drug Information Portal Mobile Site
Last updated: Dec 2018